QART (Quantitative Assisted Reproductive Technologies) Medical, a clinical-stage MedTech company, addressing the global infertility epidemic. The Company develops a breakthrough solution for highly informative characterization and selection of sperm cells for in-vitro fertilization (IVF), aiming to create a new and better gold standard in the ART market. The QART system aims to improve current success rates of Intra-Cytoplasmic Sperm Injection (ICSI) by: * Quantitatively characterizing the morphology and contents of individual sperm cells with 3D topographic imaging * Providing quantitative DNA integrity information, on a cell-by-cell basis * Automatically sorting a semen sample according to objective consensus criteria.
